# FDA Inspection 808358 - University of Texas MD Anderson Cancer Center - November 28, 2012

Source: https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/3e8863b8-6f2c-4ae4-8c60-e14b545c48ea
Source feed: FDA_Inspections

> FDA Inspection 808358 for University of Texas MD Anderson Cancer Center on November 28, 2012. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 808358
- Company Name: University of Texas MD Anderson Cancer Center
- Inspection Date: 2012-11-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169829 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/aa298c27-693d-4fd5-b74c-532feae08a95)
- [FDA Inspection 1169829 - 2022-05-12](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/b11c9269-f55e-4360-b04e-375b0f18f6d5)
- [FDA Inspection 1051600 - 2018-05-02](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/4202fc21-2fea-456c-ab71-fff48d11449e)
- [FDA Inspection 965914 - 2016-04-04](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/3f44d939-b9fe-4d7d-b567-20d022c33eae)
- [FDA Inspection 885375 - 2014-06-30](https://www.keypedia.com/records/fda_inspections/university-of-texas-md-anderson-cancer-center/790d7411-6346-4a4c-8921-c666a5824a96)

Company: https://www.keypedia.com/companies/university-of-texas-md-anderson-cancer-center/33322111-849a-4d66-8511-c5119c56dd45

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d